Cafepharma Today

May 31 2023 - Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Key FDA decisions on the horizon
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
Fierce Pharma
Thursday, May 25, 2023 - 1:10pm
tags:
Gilead Sciences, Teva Pharmaceutical, legal, HIV, antitrust
After breakup with Otsuka, Akebia finds new partner for oral anemia drug in Europe
Fierce Pharma
Thursday, May 25, 2023 - 1:07pm
tags:
Akebia Therapeutics, Medice Arzneimittel Pütter, Europe, Australia, Vafseo, chronic kidney disease
BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment
BioSpace
Thursday, May 25, 2023 - 12:52pm
tags:
BenevolentAI, layoffs
This panel will decide whose medicine to make affordable. Its choice will be tricky.
Medical Marketing and Media
Thursday, May 25, 2023 - 12:51pm
tags:
drug pricing
Digital health funding holds steady in Q1 after year of decline
BioPharma Dive
Thursday, May 25, 2023 - 12:49pm
tags:
digital health, funding
Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment
Clinical Trials Arena
Thursday, May 25, 2023 - 12:48pm
tags:
JNJ, Janssen, Tremfya, psoriasis, real world data
Medtronic Is Sweet on EOFlow
Medical Devices and Diagnostics Industry
Thursday, May 25, 2023 - 12:46pm
tags:
Medtronic, diabetes, Medtech, M&A, EOFlow
Illumina, Icahn prepare for proxy showdown
BioPharma Dive
Thursday, May 25, 2023 - 11:36am
tags:
Illumina, Carl Icahn, diagnostics, Medtech, Francis deSouza
Mirati's long wait for next lung cancer med ends in phase 3 failure
Fierce Biotech
Wednesday, May 24, 2023 - 6:53pm
tags:
Mirati Therapeutics, clinical trials, sitravantinib, lung cancer, non small cell lung cancer
Amyloid-Beta Structure Revelation Sheds Light on Leqembi’s Function
BioSpace
Wednesday, May 24, 2023 - 6:51pm
tags:
Eisai, Biogen, Alzheimer's disease, Leqembi, amyloid beta
Purdue Pharma to sell consumer business for $397 mln
Reuters
Wednesday, May 24, 2023 - 6:49pm
tags:
Purdue Pharma, M&A, consumer health, Arcardia Consumer Healthcare
Novo marks a century in business with corporate campaign launch
Medical Marketing and Media
Wednesday, May 24, 2023 - 6:48pm
tags:
Novo Nordisk, corporate branding
Noah Hits Milestone to Strengthen Place in Surging Robotics Market
Medical Devices and Diagnostics Industry
Wednesday, May 24, 2023 - 6:45pm
tags:
Noah Medical, Medtech, robotic surgery
Pharma world braces for major changes in new era of AI
Clinical Trials Arena
Wednesday, May 24, 2023 - 6:43pm
tags:
pharma industry, artificial intelligence
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
BioSpace
Wednesday, May 24, 2023 - 6:42pm
tags:
PTC Therapeutics, Friedreich's Ataxia, clinical trials, vatiquinone
FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder
Fierce Pharma
Wednesday, May 24, 2023 - 6:38pm
tags:
Braeburn Pharmaceuticals, FDA, Brixadi, opioids, opioid use disorder
FTC probes Abbott for allegedly colluding on bids for state contracts
Medical Marketing and Media
Wednesday, May 24, 2023 - 11:27am
tags:
Abbott Labs, Nestle, Reckitt Benckiser, collusion, FTC, state contracts
Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro
Fierce Pharma
Wednesday, May 24, 2023 - 11:25am
tags:
Innoviva, FDA, Entasis Therapeutics, Xacduro, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia
FDA delays decision on Duchenne gene therapy and considers narrower approval
BioPharma Dive
Wednesday, May 24, 2023 - 11:21am
tags:
Sarepta Therapeutics, FDA, DMD, Duchenne Muscular Dystrophy, gene therapy
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
Wednesday, May 24, 2023 - 11:18am
tags:
FTC, M&A, Amgen, Horizon Therapeutics, Pfizer, Seagen

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

Timeless
In the Pipeline
Drug Channels News Roundup, May 2023: 340B Shame, OptumRx vs. Humira Biosimilars, ICER on White Bagging, Hospitals vs. Taxes, and Dr. G
Drug Channels
AI and the Hard Stuff
In the Pipeline
Break Out the Purple Carrots
In the Pipeline
Five (or Maybe Six?) Reasons that the Largest PBMs Operate Group Purchasing Organizations
Drug Channels
Give Me Those Hard, Hard Numbers
In the Pipeline
The Top Pharmacy Benefit Managers of 2022: Market Share and Trends for the Biggest Companies
Drug Channels
What Exactly Does Ketamine Do For Depression?
In the Pipeline
PBMs and the Battle Over Patient Support Funds:Accumulators, Maximizers, and Alternative Funding (NEW Live Video Webinar)
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information